» GM's first-quarter U.S. vehicle sales lead industry as automakers braces for tariffs
01/04/25 21:24 from Business
GM reported a 16.7% jump in U.S. sales compared to the first quarter of 2024, led my incremental gains in sales of new EVs and notable gains in full-size SUVs.
» Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
01/04/25 20:38 from Business
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
» Airline stocks slide as concerns grow over consumers' travel appetite
01/04/25 20:34 from Business
A drop in consumer confidence and a decline in travel spending is weighing on travel stocks.
» Shares of conservative cable channel Newsmax soar another 179% after massive debut
01/04/25 20:11 from Business
Newsmax shares soared for a second day after their public debut, as the conservative news channel gains traction during President Donald Trump's second term.
» Federal funding cuts are raising questions about university endowments. Here's what some are worth and how they work
01/04/25 11:00 from Business
Columbia is one of the richest universities with a $14.8 billion endowment. Still, covering federal funding cuts isn't as simple as smashing a piggy bank.
» Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
31/03/25 20:08 from Business
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks's resignation in protest of Robert F. Kennedy Jr.
» Conservative cable channel Newsmax spikes more than 700% in first trading day on NYSE
31/03/25 20:06 from Business
The conservative cable TV channel Newsmax started trading on the New York Stock Exchange on Monday.
» AMC bets on premium screens as Hollywood slate boasts big blockbuster titles
31/03/25 16:38 from Business
Hollywood's blockbuster slate is heating up and AMC Entertainment is growing its quantity of premium screens to meet demand.
» Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
29/03/25 19:02 from Business
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
» Canadians pull back on U.S. trips, threatening to widen United States' $50 billion travel deficit
29/03/25 12:32 from Business
Some carriers are cutting back U.S. flights from Canada due to weaker demand.
» This old-school filmmaking technique is still kicking even as AI takes on a bigger role in movies
29/03/25 12:00 from Business
As Hollywood is grappling with the growing capabilities of artificial intelligence, Foley artists remain a key and deeply human part of the moviemaking process.
» ‘Wellness rooms’ are claiming space in many homes
29/03/25 04:10 from Financial Post
Our homes have been multitasking for a while now. They may be where we work, they are certainly where we play, and in today’s stress-filled world, they’re often the place where we feel most at peace. Spurred by the pandemic, ...
» Financial Results for the Fourth Quarter of 2024
29/03/25 03:39 from Financial Post
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the yea...
» Sherritt Announces Update on Noteholder Support for its Previously Announced CBCA Transaction
29/03/25 01:51 from Financial Post
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO — Sherritt International Corporation (“Sherritt” or the “Corporation”) (TSX:S) announced today an update on the level of supp...
» Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
29/03/25 01:38 from Financial Post
SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and co...
0 Comments